FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Terry Delovitch

Research Profile

Living Beings

Disorders

Type 1 Diabetes Mellitus

Anatomy

Physiology

Lymphocyte Activation

Chemicals & Drugs

Concepts & Ideas

T-Lymphocyte Subsets

Co-author Network

Publications

TOP 3
Lakshmimathy Subramanian; Robert Tohn; Carlos Aguilera; Hartley Blumenfeld; Karsten Buschard; Vipin Kumar; Dalam Ly; Jan-Eric Mansson; Igor Maricic; Terry L Delovitch
NKT cells stimulated by long fatty acyl chain sulfatides significantly reduce the incidence of type 1 diabetes in nonobese diabetic mice [corrected].
H J Blumenfeld; S M M Haeryfar; Y Liu; Paul B Savage; R Tohn; Terry L Delovitch
Structure-guided design of an invariant natural killer T cell agonist for optimum protection from type 1 diabetes in non-obese diabetic mice.
R Tohn; H Blumenfeld; S M M Haeryfar; N Veerapen; G S Besra; Steven A Porcelli; Terry L Delovitch
Stimulation of a shorter duration in the state of anergy by an invariant natural killer T cell agonist enhances its efficiency of protection from type 1 diabetes.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Terry Delovitch (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Lakshmimathy Subramanian; Robert Tohn; Carlos Aguilera; Hartley Blumenfeld; Karsten Buschard; Vipin Kumar; Dalam Ly; Jan-Eric Mansson; Igor Maricic; Terry L Delovitch
NKT cells stimulated by long fatty acyl chain sulfatides significantly reduce the incidence of type 1 diabetes in nonobese diabetic mice [corrected].
PloS one 2012;7(5):e37771.
2011: H J Blumenfeld; S M M Haeryfar; Y Liu; Paul B Savage; R Tohn; Terry L Delovitch
Structure-guided design of an invariant natural killer T cell agonist for optimum protection from type 1 diabetes in non-obese diabetic mice.
Clinical and experimental immunology 2011;166(1):121-33.
2011: R Tohn; H Blumenfeld; S M M Haeryfar; N Veerapen; G S Besra; Steven A Porcelli; Terry L Delovitch
Stimulation of a shorter duration in the state of anergy by an invariant natural killer T cell agonist enhances its efficiency of protection from type 1 diabetes.
Clinical and experimental immunology 2011;164(1):26-41.
2011: Lisa A Mannik; Ian Chin-Yee; Shayan Sharif; Luc Van Kaer; Terry L Delovitch; S M Mansour Haeryfar
Engagement of glycosylphosphatidylinositol-anchored proteins results in enhanced mouse and human invariant natural killer T cell responses.
Immunology 2011;132(3):361-75.
2010: Craig Meagher; Josh Beilke; Guillermo Arreaza; Quing Sheng Mi; Wei Chen; Konstantin Salojin; Noah Horst; William W Cruikshank; Terry L Delovitch
Neutralization of interleukin-16 protects nonobese diabetic mice from autoimmune type 1 diabetes by a CCL4-dependent mechanism.
Diabetes 2010;59(11):2862-71.
2010: Dalam Ly; R Tohn; B Rubin; H Blumenfeld; G S Besra; N Veerapen; Steven A Porcelli; Terry L Delovitch
An alpha-galactosylceramide C20:2 N-acyl variant enhances anti-inflammatory and regulatory T cell-independent responses that prevent type 1 diabetes.
Clinical and experimental immunology 2010;160(2):185-98.
2008: Shuang Wang; Hong Diao; Qiunong Guan; W W Cruikshank; Terry L Delovitch; Anthony M Jevnikar; Caigan Du
Decreased renal ischemia-reperfusion injury by IL-16 inactivation.
Kidney international 2008;73(3):318-26.
2007: Shabbir Hussain; Terry L Delovitch
Intravenous transfusion of BCR-activated B cells protects NOD mice from type 1 diabetes in an IL-10-dependent manner.
Journal of immunology (Baltimore, Md. : 1950) 2007;179(11):7225-32.
2007: Craig Meagher; Guillermo A Arreaza; Andrew Peters; Craig A Strathdee; Philippe-Alexandre Gilbert; Quing Sheng Mi; Pere Santamaria; Gregory A Dekaban; Terry L Delovitch
CCL4 protects from type 1 diabetes by altering islet beta-cell-targeted inflammatory responses.
Diabetes 2007;56(3):809-17.
2007: Terry L Delovitch
The "End of the beginning" of the immunobiology of iNKT cells in health and disease.
International reviews of immunology 2007;26(1-2):1-3.
2006: Quing Sheng Mi; Li Zhou; Marsha Grattan; Zai-Zhao Wang; M Sivilotti; Jin-Xiong She; Terry L Delovitch
Characterization of PAF-AH Ib1 in NOD mice: PAF-AH may not be a candidate gene of the diabetes susceptibility Idd4.1 locus.
Annals of the New York Academy of Sciences 2006;1079():147-52.
2006: Dalam Ly; Quing Sheng Mi; Shabbir Hussain; Terry L Delovitch
Protection from type 1 diabetes by invariant NK T cells requires the activity of CD4+CD25+ regulatory T cells.
Journal of immunology (Baltimore, Md. : 1950) 2006;177(6):3695-704.
2006: Quing Sheng Mi; Zhong-Bin Deng; Sunil K Joshi; Zai-Zhao Wang; Li Zhou; Sarah Eckenrode; Ratan Mani Joshi; Dalam Ly; Bing Yi; Terry L Delovitch; Jin-Xiong She
The autoimmune regulator (Aire) controls iNKT cell development and maturation.
Nature medicine 2006;12(9):1100.
2006: Quing Sheng Mi; Zhong-Bin Deng; Sunil K Joshi; Zai-Zhao Wang; Li Zhou; Sarah Eckenrode; Ratan Mani Joshi; Dalam Ly; Bing Yi; Terry L Delovitch; Jin-Xiong She
The autoimmune regulator (Aire) controls iNKT cell development and maturation.
Nature medicine 2006;12(6):624-6.
2005: Melany J D Wagner; Shabbir Hussain; Mala Mehan; Joseph M Verdi; Terry L Delovitch
A defect in lineage fate decision during fetal thymic invariant NKT cell development may regulate susceptibility to type 1 diabetes.
Journal of immunology (Baltimore, Md. : 1950) 2005;174(11):6764-71.
2005: Shabbir Hussain; Terry L Delovitch
Dysregulated B7-1 and B7-2 expression on nonobese diabetic mouse B cells is associated with increased T cell costimulation and the development of insulitis.
Journal of immunology (Baltimore, Md. : 1950) 2005;174(2):680-7.
2005: Shabbir Hussain; Melany Wagner; Dalam Ly; Terry L Delovitch
Role of regulatory invariant CD1d-restricted natural killer T-cells in protection against type 1 diabetes.
Immunologic research 2005;31(3):177-88.
2004: Wen Yang; Shabbir Hussain; Quing Sheng Mi; Pere Santamaria; Terry L Delovitch
Perturbed homeostasis of peripheral T cells elicits decreased susceptibility to anti-CD3-induced apoptosis in prediabetic nonobese diabetic mice.
Journal of immunology (Baltimore, Md. : 1950) 2004;173(7):4407-16.
2004: Shabbir Hussain; Konstantin V Salojin; Terry L Delovitch
Hyperresponsiveness, resistance to B-cell receptor-dependent activation-induced cell death, and accumulation of hyperactivated B-cells in islets is associated with the onset of insulitis but not type 1 diabetes.
Diabetes 2004;53(8):2003-11.
2004: Quing Sheng Mi; Dalam Ly; Peter Zucker; Megan McGarry; Terry L Delovitch
Interleukin-4 but not interleukin-10 protects against spontaneous and recurrent type 1 diabetes by activated CD1d-restricted invariant natural killer T-cells.
Diabetes 2004;53(5):1303-10.
2004: Wei Chen; Konstantin V Salojin; Quing Sheng Mi; Marsha Grattan; T Craig Meagher; Peter Zucker; Terry L Delovitch
Insulin-like growth factor (IGF)-I/IGF-binding protein-3 complex: therapeutic efficacy and mechanism of protection against type 1 diabetes.
Endocrinology 2004;145(2):627-38.
2003: Quing Sheng Mi; Dalam Ly; S-E Lamhamedi-Cherradi; Konstantin V Salojin; Li Zhou; Marsha Grattan; Craig Meagher; Peter Zucker; Youhai H Chen; James Nagle; Dennis Taub; Terry L Delovitch
Blockade of tumor necrosis factor-related apoptosis-inducing ligand exacerbates type 1 diabetes in NOD mice.
Diabetes 2003;52(8):1967-75.
2003: Guillermo A Arreaza; Konstantin V Salojin; Wen Yang; Jian Zhang; Bruce Gill; Quing Sheng Mi; Jian-Xin Gao; Craig Meagher; Mark Cameron; Terry L Delovitch
Deficient activation and resistance to activation-induced apoptosis of CD8+ T cells is associated with defective peripheral tolerance in nonobese diabetic mice.
Clinical immunology (Orlando, Fla.) 2003;107(2):103-15.
2003: S Brian Wilson; Terry L Delovitch
Janus-like role of regulatory iNKT cells in autoimmune disease and tumour immunity.
Nature reviews. Immunology 2003;3(3):211-22.
2003: Quing Sheng Mi; Craig Meagher; Terry L Delovitch
CD1d-restricted NKT regulatory cells: functional genomic analyses provide new insights into the mechanisms of protection against Type 1 diabetes.
Novartis Foundation symposium 2003;252():146-60; discussion 160-4, 203-10.
2003: Craig Meagher; Shayan Sharif; S Hussain; Mark Cameron; Guillermo A Arreaza; Terry L Delovitch
Cytokines and chemokines in the pathogenesis of murine type 1 diabetes.
Advances in experimental medicine and biology 2003;520():133-58.
2002: Shayan Sharif; Guillermo A Arreaza; Peter Zucker; Quing Sheng Mi; Terry L Delovitch
Regulation of autoimmune disease by natural killer T cells.
Journal of molecular medicine (Berlin, Germany) 2002;80(5):290-300.
2002: Shayan Sharif; Guillermo A Arreaza; Peter Zucker; Terry L Delovitch
Regulatory natural killer T cells protect against spontaneous and recurrent type 1 diabetes.
Annals of the New York Academy of Sciences 2002;958():77-88.
2002: Marsha Grattan; Quing Sheng Mi; Craig Meagher; Terry L Delovitch
Congenic mapping of the diabetogenic locus Idd4 to a 5.2-cM region of chromosome 11 in NOD mice: identification of two potential candidate subloci.
Diabetes 2002;51(1):215-23.
2001: W Chen; I Bergerot; John Elliott; L C Harrison; Norio Abiru; G S Eisenbarth; Terry L Delovitch
Evidence that a peptide spanning the B-C junction of proinsulin is an early Autoantigen epitope in the pathogenesis of type 1 diabetes.
Journal of immunology (Baltimore, Md. : 1950) 2001;167(9):4926-35.
2001: Shayan Sharif; Guillermo A Arreaza; Peter Zucker; Quing Sheng Mi; J Sondhi; Olga V Naidenko; Mitchell Kronenberg; Yasuhiko Koezuka; Terry L Delovitch; Jean-Marc Gombert; Maria C Leite-de-Moraes; Christine Gouarin; Ren Zhu; A Hameg; T Nakayama; M Taniguchi; Françoise Lepault; Agnès Lehuen; Jean-François Bach; André Herbelin
Activation of natural killer T cells by alpha-galactosylceramide treatment prevents the onset and recurrence of autoimmune Type 1 diabetes.
Nature medicine 2001;7(9):1057-62.
2001: Jian Zhang; Konstantin V Salojin; Terry L Delovitch
CD28 co-stimulation restores T cell responsiveness in NOD mice by overcoming deficiencies in Rac-1/p38 mitogen-activated protein kinase signaling and IL-2 and IL-4 gene transcription.
International immunology 2001;13(3):377-84.
2001: Shayan Sharif; Terry L Delovitch
Regulation of immune responses by natural killer T cells.
Archivum immunologiae et therapiae experimentalis 2001;49 Suppl 1():S23-31.
2001: Guillermo A Arreaza; Shayan Sharif; Mark Cameron; W Chen; Terry L Delovitch
Role of regulatory T cells in the pathogenesis of autoimmune diabetes.
Current directions in autoimmunity 2001;4():308-32.
2000: Bhagirath Singh; Terry L Delovitch
Immune mechanisms that regulate susceptibility to autoimmune type I diabetes.
Clinical reviews in allergy & immunology 2000;19(3):247-64.
2000: Mark Cameron; Guillermo A Arreaza; L Waldhauser; J Gauldie; Terry L Delovitch
Immunotherapy of spontaneous type 1 diabetes in nonobese diabetic mice by systemic interleukin-4 treatment employing adenovirus vector-mediated gene transfer.
Gene therapy 2000;7(21):1840-6.
2000: Mark Cameron; Craig A Strathdee; Kevin D Holmes; Guillermo A Arreaza; Gregory A Dekaban; Terry L Delovitch
Biolistic-mediated interleukin 4 gene transfer prevents the onset of type 1 diabetes.
Human gene therapy 2000;11(12):1647-56.
2000: Mark Cameron; Guillermo A Arreaza; Marsha Grattan; Craig Meagher; Shayan Sharif; M D Burdick; RM Strieter; D N Cook; Terry L Delovitch
Differential expression of CC chemokines and the CCR5 receptor in the pancreas is associated with progression to type I diabetes.
Journal of immunology (Baltimore, Md. : 1950) 2000;165(2):1102-10.
2000: Jian-Xin Gao; Jian Zhang; Christian Awaraji; Mickie Bhatia; Anthony M Jevnikar; B Singh; D Bell; Terry L Delovitch
Preferential proliferation and differentiation of double-positive thymocytes into CD8(+) single-positive thymocytes in a novel cell culture medium.
Cellular immunology 2000;202(1):41-53.
2000: Jian Zhang; Jian-Xin Gao; Konstantin V Salojin; Q Shao; Marsha Grattan; Craig Meagher; D W Laird; Terry L Delovitch
Regulation of fas ligand expression during activation-induced cell death in T cells by p38 mitogen-activated protein kinase and c-Jun NH2-terminal kinase.
The Journal of experimental medicine 2000;191(6):1017-30.
2000: Konstantin V Salojin; Jian Zhang; Craig Meagher; Terry L Delovitch
ZAP-70 is essential for the T cell antigen receptor-induced plasma membrane targeting of SOS and Vav in T cells.
The Journal of biological chemistry 2000;275(8):5966-75.
1999: I Bergerot; Guillermo A Arreaza; Mark Cameron; M D Burdick; RM Strieter; Stephen W Chensue; Subrata Chakrabarti; Terry L Delovitch
Insulin B-chain reactive CD4+ regulatory T-cells induced by oral insulin treatment protect from type 1 diabetes by blocking the cytokine secretion and pancreatic infiltration of diabetogenic effector T-cells.
Diabetes 1999;48(9):1720-9.
1999: Konstantin V Salojin; Jian Zhang; Terry L Delovitch
TCR and CD28 are coupled via ZAP-70 to the activation of the Vav/Rac-1-/PAK-1/p38 MAPK signaling pathway.
Journal of immunology (Baltimore, Md. : 1950) 1999;163(2):844-53.
1999: Jian Zhang; Konstantin V Salojin; Jian-Xin Gao; Mark Cameron; I Bergerot; Terry L Delovitch
p38 mitogen-activated protein kinase mediates signal integration of TCR/CD28 costimulation in primary murine T cells.
Journal of immunology (Baltimore, Md. : 1950) 1999;162(7):3819-29.
1998: Konstantin V Salojin; Jian Zhang; J Madrenas; Terry L Delovitch
T-cell anergy and altered T-cell receptor signaling: effects on autoimmune disease.
Immunology today 1998;19(10):468-73.
1998: Jian Zhang; Konstantin V Salojin; Jian-Xin Gao; Mark Cameron; C Geisler; Terry L Delovitch
TCR alpha beta chains associate with the plasma membrane independently of CD3 and TCR zeta chains in murine primary T cells.
Journal of immunology (Baltimore, Md. : 1950) 1998;161(6):2930-7.
1998: Mark Cameron; Craig Meagher; Terry L Delovitch
Failure in immune regulation begets IDDM in NOD mice.
Diabetes/metabolism reviews 1998;14(2):177-85.
1998: Jian Zhang; Konstantin V Salojin; Terry L Delovitch
Sequestration of CD4-associated Lck from the TCR complex may elicit T cell hyporesponsiveness in nonobese diabetic mice.
Journal of immunology (Baltimore, Md. : 1950) 1998;160(3):1148-57.
1997: Terry L Delovitch; Bhagirath Singh
The nonobese diabetic mouse as a model of autoimmune diabetes: immune dysregulation gets the NOD.
Immunity 1997;7(6):727-38.
1997: Mark Cameron; Guillermo A Arreaza; Peter Zucker; Stephen W Chensue; RM Strieter; Subrata Chakrabarti; Terry L Delovitch
IL-4 prevents insulitis and insulin-dependent diabetes mellitus in nonobese diabetic mice by potentiation of regulatory T helper-2 cell function.
Journal of immunology (Baltimore, Md. : 1950) 1997;159(10):4686-92.
1997: Guillermo A Arreaza; Mark Cameron; A Jaramillo; B M Gill; D Hardy; K B Laupland; M J Rapoport; Peter Zucker; Subrata Chakrabarti; Stephen W Chensue; H Y Qin; Bhagirath Singh; Terry L Delovitch
Neonatal activation of CD28 signaling overcomes T cell anergy and prevents autoimmune diabetes by an IL-4-dependent mechanism.
The Journal of clinical investigation 1997;100(9):2243-53.
1997: Konstantin V Salojin; Jian Zhang; Mark Cameron; B Gill; Guillermo A Arreaza; A Ochi; Terry L Delovitch
Impaired plasma membrane targeting of Grb2-murine son of sevenless (mSOS) complex and differential activation of the Fyn-T cell receptor (TCR)-zeta-Cbl pathway mediate T cell hyporesponsiveness in autoimmune nonobese diabetic mice.
The Journal of experimental medicine 1997;186(6):887-97.
1997: I Bergerot; Guillermo A Arreaza; Mark Cameron; H Chou; Terry L Delovitch
Role of T-cell anergy and suppression in susceptibility to IDDM.
Research in immunology 1997;148(5):348-58.
1997: Mark Cameron; Guillermo A Arreaza; Terry L Delovitch
Cytokine- and costimulation-mediated therapy of IDDM.
Critical reviews in immunology 1997;17(5-6):537-44.
1996: Y Lang; F Forquet; E Speck; J Blum; Terry L Delovitch
Major histocompatibility complex class II molecules function as a template for the processing of a partially processed insulin peptide into a T-cell epitope.
Diabetes 1996;45(12):1711-9.
1996: K Kawauchi; Alan H Lazarus; J S Sanghera; G L Man; S L Pelech; Terry L Delovitch
Regulation of BCR- and PKC/Ca(2+)-mediated activation of the Raf1/MEK/MAPK pathway by protein-tyrosine kinase and -tyrosine phosphatase activities.
Molecular immunology 1996;33(3):287-96.
1995: B Vukusic; L Poplonski; L Phillips; J Pawling; Terry L Delovitch; Nobumichi Hozumi; Joan E Wither
Both MHC and background gene heterozygosity alter T cell receptor repertoire selection in an antigen-specific response.
Molecular immunology 1995;32(17-18):1355-67.
1995: BM Gill; A Jaramillo; L Ma; K B Laupland; Terry L Delovitch
Genetic linkage of thymic T-cell proliferative unresponsiveness to mouse chromosome 11 in NOD mice. A possible role for chemokine genes.
Diabetes 1995;44(6):614-9.
1994: BM Gill; H Nishikata; G Chan; Terry L Delovitch; Atsuo Ochi
Fas antigen and sphingomyelin-ceramide turnover-mediated signaling: role in life and death of T lymphocytes.
Immunological reviews 1994;142():113-25.
1994: U G Danliczyk; Terry L Delovitch
Beta 2-microglobulin induces a conformational change in an MHC class I H chain that occurs intracellularly and is maintained at the cell surface.
Journal of immunology (Baltimore, Md. : 1950) 1994;153(8):3533-42.
1994: F Forquet; M Hadzija; John W Semple; E Speck; Terry L Delovitch
Naturally processed heterodimeric disulfide-linked insulin peptides bind to major histocompatibility class II molecules on thymic epithelial cells.
Proceedings of the National Academy of Sciences of the United States of America 1994;91(9):3936-40.
1994: K Kawauchi; Alan H Lazarus; M J Rapoport; A Harwood; John C Cambier; Terry L Delovitch
Tyrosine kinase and CD45 tyrosine phosphatase activity mediate p21ras activation in B cells stimulated through the antigen receptor.
Journal of immunology (Baltimore, Md. : 1950) 1994;152(7):3306-16.
1994: A Jaramillo; BM Gill; Terry L Delovitch
Insulin dependent diabetes mellitus in the non-obese diabetic mouse: a disease mediated by T cell anergy?
Life sciences 1994;55(15):1163-77.
1993: Alan H Lazarus; K Kawauchi; M J Rapoport; Terry L Delovitch
Antigen-induced B lymphocyte activation involves the p21ras and ras.GAP signaling pathway.
The Journal of experimental medicine 1993;178(5):1765-9.
1993: Michael R Christie; J A Hollands; T J Brown; B K Michelsen; Terry L Delovitch
Detection of pancreatic islet 64,000 M(r) autoantigens in insulin-dependent diabetes distinct from glutamate decarboxylase.
The Journal of clinical investigation 1993;92(1):240-8.
1993: M J Rapoport; A Jaramillo; D Zipris; Alan H Lazarus; D V Serreze; E H Leiter; P Cyopick; Jayne S Danska; Terry L Delovitch
Interleukin 4 reverses T cell proliferative unresponsiveness and prevents the onset of diabetes in nonobese diabetic mice.
The Journal of experimental medicine 1993;178(1):87-99.
1993: M J Rapoport; Alan H Lazarus; A Jaramillo; E Speck; Terry L Delovitch
Thymic T cell anergy in autoimmune nonobese diabetic mice is mediated by deficient T cell receptor regulation of the pathway of p21ras activation.
The Journal of experimental medicine 1993;177(4):1221-6.
1993: A Krook; M J Rapoport; S Anderson; H Pross; Y C Zhou; D T Denhardt; Terry L Delovitch; T Haliotis
p21ras and protein kinase C function in distinct and interdependent signaling pathways in C3H 10T1/2 fibroblasts.
Molecular and cellular biology 1993;13(3):1471-9.
1993: F Forquet; U Danilczyk; Y Lang; Terry L Delovitch
Interactions between peptides and major histocompatibility complex molecules during antigen processing and presentation.
Chemical immunology 1993;57():63-87.
1992: John W Semple; Y Lang; E R Speck; Terry L Delovitch
Processing and presentation of insulin. III. Insulin degrading enzyme: a neutral metalloendoproteinase that is non-homologous to classical endoproteinases mediates the processing of insulin epitopes for helper T cells.
International immunology 1992;4(10):1161-7.
1991: Alan H Lazarus; Gordon B Mills; Andrew R Crow; Terry L Delovitch
Antigen-induced Fc receptor-dependent and -independent B cell desensitization. An elevation in [Ca2+]i is not sufficient and protein kinase C activation is not required for these pathways of surface IgM-mediated desensitization.
Journal of immunology (Baltimore, Md. : 1950) 1991;147(6):1739-45.
1991: D Zipris; Alan H Lazarus; Andrew R Crow; M Hadzija; Terry L Delovitch
Defective thymic T cell activation by concanavalin A and anti-CD3 in autoimmune nonobese diabetic mice. Evidence for thymic T cell anergy that correlates with the onset of insulitis.
Journal of immunology (Baltimore, Md. : 1950) 1991;146(11):3763-71.
1991: M Hadzija; John W Semple; Terry L Delovitch
Influence of antigen processing on thymic T-cell selection.
Research in immunology 1991;142(5-6):421-4.
1991: Joan E Wither; J Pawling; L Phillips; Terry L Delovitch; Nobumichi Hozumi
Amino acid residues in the T cell receptor CDR3 determine the antigenic reactivity patterns of insulin-reactive hybridomas.
Journal of immunology (Baltimore, Md. : 1950) 1991;146(10):3513-22.
1991: D Zipris; Andrew R Crow; Terry L Delovitch
Altered thymic and peripheral T-lymphocyte repertoire preceding onset of diabetes in NOD mice.
Diabetes 1991;40(4):429-35.
1991: J W Semple; Terry L Delovitch
Altered processing of human insulin by B lymphocytes from an immunologically insulin-resistant type I diabetic patient.
Journal of autoimmunity 1991;4(2):277-89.
1990: Michael R Christie; G Vohra; P Champagne; Denis Daneman; Terry L Delovitch
Distinct antibody specificities to a 64-kD islet cell antigen in type 1 diabetes as revealed by trypsin treatment.
The Journal of experimental medicine 1990;172(3):789-94.
1990: Alan H Lazarus; Gordon B Mills; Terry L Delovitch
Antigen-induced Ca2+ signaling and desensitization in B cells.
Journal of immunology (Baltimore, Md. : 1950) 1990;144(11):4147-55.
1990: Michael R Christie; Denis Daneman; P Champagne; Terry L Delovitch
Persistence of serum antibodies to 64,000-Mr islet cell protein after onset of type I diabetes.
Diabetes 1990;39(6):653-6.
1990: D Tibensky; Terry L Delovitch
Promoter region of HLA-C genes: regulatory elements common to and different from those of HLA-A and HLA-B genes.
Immunogenetics 1990;32(3):210-3.
1989: P Naquet; J Ellis; A Kenshole; John W Semple; Terry L Delovitch
Sulfated beef insulin treatment elicits CD8+ T cells that may abrogate immunologic insulin resistance in type I diabetes.
The Journal of clinical investigation 1989;84(5):1479-87.
1989: D Tibensky; R DeMars; E W Holowachuk; Terry L Delovitch
Sequence and gene transfer analyses of HLA-CwBL18 (HLA-C blank) and HLA-Cw5 genes. Implications for the control of expression and immunogenicity of HLA-C antigens.
Journal of immunology (Baltimore, Md. : 1950) 1989;143(1):348-55.
1989: J W Semple; J Ellis; Terry L Delovitch
Processing and presentation of insulin. II. Evidence for intracellular, plasma membrane-associated and extracellular degradation of human insulin by antigen-presenting B cells.
Journal of immunology (Baltimore, Md. : 1950) 1989;142(12):4184-93.
1989: N F Bernard; P Naquet; M Watanabe; Nobumichi Hozumi; Terry L Delovitch
Influence of the valency and hydrophobicity of an antigen on its efficiency of processing and presentation by antigen-specific B cells.
Research in immunology 1989;140(5-6):563-79.
1989: Terry L Delovitch; Alan H Lazarus; M L Phillips; John W Semple
Antigen binding and processing by B-cell antigen-presenting cells: influence on T- and B-cell activation.
Cold Spring Harbor symposia on quantitative biology 1989;54 Pt 1():333-43.
1988: Terry L Delovitch; John W Semple; P Naquet; N F Bernard; J Ellis; P Champagne; M L Phillips
Pathways of processing of insulin by antigen-presenting cells.
Immunological reviews 1988;106():195-222.
1988: J W Semple; S A Cockle; Terry L Delovitch
Purification and characterization of radiolabelled biosynthetic human insulin from Escherichia coli. Kinetics of processing by antigen presenting cells.
Molecular immunology 1988;25(12):1291-8.
1988: N F Bernard; P C Reid; M L Phillips; Terry L Delovitch
Correlation of presentation of insulin with surface I-Ad and A alpha and A beta mRNA expression by cloned B lymphoma hybridoma variants.
Immunology letters 1988;19(2):143-51.
1988: Terry L Delovitch; J W Semple; M L Phillips
Influence of antigen processing on immune responsiveness.
Immunology today 1988;9(7-8):216-8.
1988: P Naquet; J Ellis; D Tibensky; A Kenshole; Bhagirath Singh; R Hodges; Terry L Delovitch
T cell autoreactivity to insulin in diabetic and related non-diabetic individuals.
Journal of immunology (Baltimore, Md. : 1950) 1988;140(8):2569-78.
1988: D Tibensky; F Decary; Terry L Delovitch
HLA-C genes are transcribed in HLA-C blank individuals.
Immunogenetics 1988;27(3):220-4.
1987: P Naquet; J Ellis; Bhagirath Singh; R S Hodges; Terry L Delovitch
Processing and presentation of insulin. I. Analysis of immunogenic peptides and processing requirements for insulin A loop-specific T cells.
Journal of immunology (Baltimore, Md. : 1950) 1987;139(12):3955-63.